High Blood Pressure Contributing Factors in Young Age People: An Overview Study
Abstract
Abstract:
Three of the six main causes of cardiovascular illness worldwide include hypertension. high blood pressure markedly raises the likelihood of coronary artery disease, stroke, and kidney damage. We searched Google Scholar and PubMed for articles on risk variables related to young-onset high blood pressure. The search terms we used were causes, being young individuals, and "high blood pressure. The qualification tests were administered in a non-blinded, standardized manner. For every manuscript, the initial writer, the year that it was published, the topic concerning young people's high blood pressure, and danger variables influencing younger adults' hypertension have been extracted. A query of the PubMed database produced 150 articles. We reviewed ten manuscripts in total, all of whose have been released within 2017 and 2021. Foreign study teams conducted the majority of the analyses that were taken into consideration. Individuals who have excess fat, cigarette smoke, chewing nicotine, drinking alcoholic beverages, lead dull lives, consume excessive amounts of saltwater, and lead poor habits were more likely to acquire high blood pressure. Apart from the previously mentioned causes, there exist other significant warning characteristics, including but not limited to lack of education, ignorance of disease, contempt regarding one's own wellness, and a societal norm that prioritizes men over women. Individuals who are adapting to occidental society are causing a profound change in their way of life. The main causes of high blood pressure were obesity, alcohol consumption, tobacco use, and a high sodium intake. This demonstrates that raising public knowledge of and perspectives regarding avoiding the development and treatment of high blood pressure is crucial for leading lives that are healthier and more enjoyable.
Full text article
References
Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18(2):73-8.
International Society of Hypertension. [ Dec; 2016 ]. 2016. http://www.ish-world.com
Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011;377(9765):568-77.
World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization; 2009 Oct 28.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747-57.
World Health Organization: A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. [ Oct; 2017 ].
El Bcheraoui C, Memish ZA, Tuffaha M, Daoud F, Robinson M, Jaber S, et al. Hypertension and its associated risk factors in the kingdom of saudi arabia, 2013: a national survey. Int J Hypertens. 2014;2014:564679.
Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 - United States, 2011-2016. MMWR Morb Mortal Wkly Rep. 2018;67(35):983-91.
Gan SK, Loh CY, Seet B. Hypertension in young adults--an under-estimated problem. Singapore Med J. 2003;44(9):448-52.
Xu X, Byles J, Shi Z, McElduff P, Hall J. Dietary pattern transitions, and the associations with BMI, waist circumference, weight and hypertension in a 7-year follow-up among the older Chinese population: a longitudinal study. BMC Public Health. 2016;16:743.
De Venecia T, Lu M, Figueredo VM. Hypertension in young adults. Postgraduate medicine. 2016 Feb 17;128(2):201-7.
Johnson HM, Thorpe CT, Bartels CM, Schumacher JR, Palta M, Pandhi N, Sheehy AM, Smith MA. Undiagnosed hypertension among young adults with regular primary care use. Journal of hypertension. 2014 Jan 1;32(1):65-74.
Johnson HM, Thorpe CT, Bartels CM, Schumacher JR, Palta M, Pandhi N, Sheehy AM, Smith MA. Antihypertensive medication initiation among young adults with regular primary care use. Journal of general internal medicine. 2014 May;29:723-31.
Gupta P, Nagaraju SP, Gupta A, Chikkalingaiah KB. Prehypertension-time to act. Saudi Journal of Kidney Diseases and Transplantation. 2012 Mar 1;23(2):223-33.
Elliott WJ, Black HR. Prehypertension. Nature Clinical Practice Cardiovascular Medicine. 2007 Oct;4(10):538-48.
World Hypertension League. [ Dec; 2016 ]. 2016. http://www.worldhypertensionleague.org
World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of hypertension. 2003 Nov 1;21(11):1983-92.
Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V. Hypertension crisis. Blood pressure. 2010 Dec 1;19(6):328-36.
Omvik P. How smoking affects blood pressure. Blood pressure. 1996 Jan 1;5(2):71-7.
Verdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L, Norgiolini S, Bracco C, Porcellati C. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension. 2004 May 1;43(5):963-9.
Rigaud AS, Seux ML, Staessen JA, Birkenhäger WH, Forette F. Cerebral complications of hypertension. Journal of human hypertension. 2000 Oct;14(10):605-16.
Singh S, Shankar R, Singh GP. Prevalence and Associated Risk Factors of Hypertension: A Cross‐Sectional Study in Urban Varanasi. International journal of hypertension. 2017;2017(1):5491838.
AlWabel AH, Almufadhi MA, Alayed FM, Aloraini AY, Alobaysi HM, Alalwi RM. Assessment of hypertension and its associated risk factors among medical students in Qassim University. Saudi Journal of Kidney Diseases and Transplantation. 2018 Sep 1;29(5):1100-8.
Hu L, Huang X, You C, Li J, Hong K, Li P, Wu Y, Wu Q, Wang Z, Gao R, Bao H. Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PloS one. 2017 Sep 14;12(9):e0183934.
Ondimu DO, Kikuvi GM, Otieno WN. Risk factors for hypertension among young adults (18-35) years attending in Tenwek Mission Hospital, Bomet County, Kenya in 2018. Pan African Medical Journal. 2019 Jul 15;33(1).
Liu X, Xiang Z, Shi X, Schenck H, Yi X, Ni R, Liu C. The Risk Factors of High Blood Pressure among Young Adults in the Tujia‐Nationality Settlement of China. BioMed Research International. 2017;2017(1):8315603.
Paul GK, Karmoker KK, Sen B, Hussain MZ, Hasan MS, Khan MK. Risk factors for hypertension in young adults of Bangladesh. Mymensingh Med J. 2020 Jan;29(1):43-7.
Amanyire J, Tumwebaze M, Mugisha MK, Bright LW. Prevalence and risk factors for hypertension, diabetes and obesity among lecturers and support staff of Bishop Stuart University in Mbarara, Uganda. Open Journal of Applied Sciences. 2019 Mar 12;9(3):126-37.
Tymejczyk O, McNairy ML, Petion JS, Rivera VR, Dorelien A, Peck M, Seo G, Walsh KF, Fitzgerald DW, Peck RN, Joshi A. Hypertension prevalence and risk factors among residents of four slum communities: population-representative findings from Port-au-Prince, Haiti. Journal of hypertension. 2019 Apr 1;37(4):685-95.
Mouhtadi BB, Kanaan RM, Iskandarani M, Rahal MK, Halat DH. Prevalence, awareness, treatment, control and risk factors associated with hypertension in Lebanese adults: A cross sectional study. Global cardiology science & practice. 2018 Mar 3;2018(1).
Van NB, Hoang LV, Van TB, Anh HN, Minh HT, Do Nam K, Tri TN, Show PL, Nga VT, Raj DB, Chu DT. Correction to: prevalence and risk factors of hypertension in the Vietnamese elderly. High blood pressure & cardiovascular prevention: the official journal of the Italian Society of Hypertension. 2020 Apr;27(2):175.
Lawes CM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.
Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ. 1992;146:1997–2005.
Khan N, Wardman D, Campbell N. Differences in need for antihypertensive drugs among those aware and unaware of their hypertensive status: A cross sectional survey. BMC Cardiovasc Disord. 2005;5:4.
Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547–59.
Yusuf S, Teo K, Anderson C, et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. Lancet. 2008;372:1174–83.
Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–28.
Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: A cluster randomized, controlled trial. Hypertension. 2009;53:646–53.
Strazzullo P, D’Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: Meta-analysis of prospective studies. BMJ. 2009;339:b4567.
McAlister FA. The Canadian Hypertension Education Program – a unique Canadian initiative. Can J Cardiol. 2006;22:559–64.
Institute of Medicine Panel on Dietary Reference Intakes for Electrolytes and Water. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate/Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Washington: National Academies Press; 2009.
Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP) BMJ. 2007;334:885.
Joffres MR, Campbell NR, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol. 2007;23:437–43.
Campbell NR, Khan NA, Hill MD, et al. 2009 Canadian Hypertension Education Program recommendations: The scientific summary – an annual update. Can J Cardiol. 2009;25:271–7.
Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy. Can J Cardiol. 2009;25:287–98.
Genest J, McPherson R, Frohlich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Can J Cardiol. 2009;25:567–79.
Weber MA, Bakris GL, Dahlof B, et al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk. Blood Press. 2007;16:13–9.
Staessen JA, Li Y, Richart T. Oral renin inhibitors. Lancet. 2006;368:1449–56.
Solomon SD, Appelbaum E, Manning WJ, et al. Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation. 2009;119:530–7.
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure (ASTRONAUT). ClinicalTrials.gov Identifier: NCT00894387.
Parving HH, Brenner BM, McMurray J, et al. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): Rationale and study design. Nephrol Dial Transplant. 2009;24:1663–71.
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure (ATMOSPHERE). ClinicalTrials.gov Identifier: NCT00853658.
Lambers Heerspink HJ, Perkovic V, de Zeeuw D. Renal and cardio-protective effects of direct renin inhibition: A systematic literature review. J Hypertens. 2009;27:2321–31.
Authors
Copyright (c) 2024 Journal of Current Medical Research and Opinion
This work is licensed under a Creative Commons Attribution 4.0 International License.